Radiation dose in non-small cell lung cancer: Too much of a good thing?

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 5, 2014, Pages 979-982

  Dilling, Thomas J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; NON SMALL CELL LUNG CANCER; NOTE; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STEREOTACTIC BODY RADIATION THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; HIGH VOLUME HOSPITAL; INCIDENCE; LUNG NEOPLASMS; MORTALITY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; RADIATION INJURIES; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT; CARBOPLATIN; CETUXIMAB; MONOCLONAL ANTIBODY; PACLITAXEL;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DOSE FRACTIONATION; HOSPITALS, HIGH-VOLUME; HUMANS; INCIDENCE; LUNG NEOPLASMS; PACLITAXEL; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETREATMENT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84920032645     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.08.333     Document Type: Note

References (13)

1. J.D. Bradley, R. Paulus, and R. Komaki A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617 J Clin Oncol 31 Suppl 2013 Abstr 7501
2. G. Blumenschein, H. Moughan, and W. Curran A phase II study of cetuximab C225 in combination with chemoradiation (CRT) in patients (Pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial J Clin Oncol 25 Suppl 2007 S392
3. B.D. Minsky, T.F. Pajak, and R.J. Ginsberg INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
4. B. Movsas, C. Hu, and J. Sloan Quality of life (QOL) analysis of the randomized radiation (RT) dose-escalation NSCLC trial (RTOG 0617): The rest of the story Int J Radiat Oncol Biol Phys 87 2013 S1 S2
5. B.R. Eaton, S.L. Pugh, and J.D. Bradley The effect of institutional clinical trial enrollment volume on survival of patients with stage III non-small cell lung cancer treated with chemoradiation: A report of the Radiation Therapy Oncology Group (RTOG) 0617 J Clin Oncol 32 Suppl 2014 Abstr 7551
6. A.D. Jensen, M.W. Münter, and H.G. Bischoff Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab Cancer 117 2011 2986 2994
7. A. Hallqvist, G. Wagenius, and H. Rylander Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite - a phase II study from the Swedish Lung Cancer Study Group Lung Cancer 71 2011 166 172
8. T.J. Dilling, M. Extermann, and J. Kim Phase II study of concurrent cetuximab (C225) plus definitive thoracic radiotherapy (XRT) followed by adjuvant docetaxel in pooor prognosis patients with locally advanced non-small cell lung cancer (LA-NSCLC) J Clin Oncol 30 Suppl 2012 Abstr 7065
9. M. Saunders, S. Dische, and A. Barrett Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART Steering Committee Radiother Oncol 52 1999 137 148
10. D.M. Cannon, M.P. Mehta, and J.B. Adkison Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer J Clin Oncol 31 2013 4343 4348
11. G.H. Griffioen, M. Dahele, and P.F. de Haan High-dose, conventionally fractionated thoracic reirradiation for lung tumors Lung Cancer 83 2014 356 362
12. T.R. Meijneke, S.F. Petit, and D. Wentzler Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity Radiother Oncol 107 2013 423 427
13. S.A. McAvoy, K.T. Ciura, and J.M. Rineer Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer Radiother Oncol 109 2013 38 44